Patient Outcomes on Day 4 of Intravenous Antibiotic Therapy in Non–Intensive Care Unit Hospitalized Adults With Community-Acquired Bacterial Pneumonia

BACKGROUND: Community-acquired bacterial pneumonia (CABP) is a leading cause of morbidity and mortality especially in hospitalized patients. In place of clinical end points traditionally used to evaluate antimicrobial efficacy for its treatment, Food and Drug Administration guidelines now require al...

Descripción completa

Detalles Bibliográficos
Autores principales: Robinson, Scott B., Ernst, Frank R., Lipkin, Craig, Huang, Xingyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams & Wilkins 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232336/
https://www.ncbi.nlm.nih.gov/pubmed/25411532
http://dx.doi.org/10.1097/IPC.0000000000000143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232336/
https://www.ncbi.nlm.nih.gov/pubmed/25411532
http://dx.doi.org/10.1097/IPC.0000000000000143

Ejemplares similares